论文部分内容阅读
目的:观察米非司酮联合甲氨蝶呤治疗宫外孕的临床效果。方法:选取2014年1月至2014年12月期间我院收治的宫外孕患者80例,随机将患者分为观察组与对照组,每组患者40例。对照组患者以药物米非司酮进行治疗;观察组患者在此基础上联合甲氨蝶呤进行治疗,对两组患者的治疗效果进行比较。结果:观察组治疗成功率为92.5%;对照组治疗成功率为77.5%,组间差异具有统计学意义(P<0.05)。两组患者不良反应发生率无显著差异(P>0.05)。结论:米非司酮联合氨甲喋呤治疗宫外孕效果显著,安全性高,值得在临床上广泛推广使用。
Objective: To observe the clinical effect of mifepristone combined with methotrexate in the treatment of ectopic pregnancy. Methods: 80 patients with ectopic pregnancy admitted to our hospital from January 2014 to December 2014 were randomly divided into observation group and control group, with 40 patients in each group. The patients in the control group were treated with mifepristone. The patients in the observation group were treated with methotrexate on the basis of this treatment, and the treatment effect was compared between the two groups. Results: The success rate of treatment in the observation group was 92.5%. The success rate of treatment in the control group was 77.5%. The difference between the two groups was statistically significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: Mifepristone combined with methotrexate treatment of ectopic pregnancy significant effect, high safety, it is worth widely used in clinical practice.